These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 395128)

  • 21. Compliance and improvement in drug-treated and placebo-treated neurotic outpatients.
    Rickels K; Downing R
    Arch Gen Psychiatry; 1966 Jun; 14(6):631-3. PubMed ID: 5327339
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazepam in the treatment of psychoneurotic outpatients: a brief report.
    Silver D; Ban TA; Kristof FE; Saxena BM; Bennett J
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):596-8. PubMed ID: 4981302
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychotropic drug treatment of mixed anxiety and depression in nonpsychiatric office patients: expected and unexpected findings--comparing doxepin, chlordiazepoxide and placebo.
    Goldstein BJ; Brauzer B; Steinbook RM; Jacobson AF
    South Med J; 1973 Aug; 66(8):892-7. PubMed ID: 4578609
    [No Abstract]   [Full Text] [Related]  

  • 25. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxepin in the treatment of psychoneurotic patients.
    Beaubien J; Ban TA; Lehman HE; Jarrold L
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):192-4. PubMed ID: 4985939
    [No Abstract]   [Full Text] [Related]  

  • 27. A DOUBLE BLIND TEST ON THE EFFECT OF CHLORDIAZPEPOXIDE (LIBRIUM) IN ANXIETY NEUROSIS.
    CHIEN CP; TSUANG MT; RIN H
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1963 Apr; 62():286-91. PubMed ID: 14132447
    [No Abstract]   [Full Text] [Related]  

  • 28. Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.
    Lipman RS; Covi L; Rickels K; McNair DM; Downing R; Kahn RJ; Lasseter VK; Faden V
    Arch Gen Psychiatry; 1986 Jan; 43(1):68-77. PubMed ID: 3510601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study.
    Kellner R; Wilson RM; Muldawer MD; Pathak D
    Arch Gen Psychiatry; 1975 Oct; 32(10):1246-54. PubMed ID: 241306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness.
    Feighner JP; Brauzer B; Gelenberg AJ; Gomez E; Kiev A; Kurland ML; Weiss BL
    Psychopharmacology (Berl); 1979 Mar; 61(2):217-25. PubMed ID: 108739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice.
    Montgomery BA; Cullinan TR; Bayley AJ
    Br J Clin Pract; 1970 May; 24(5):207-9. PubMed ID: 4916190
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.
    Covi L; Lipman RS; Pattison JH; Derogatis LR; Uhlenhuth EH
    Acta Psychiatr Scand; 1973; 49(1):51-64. PubMed ID: 4572168
    [No Abstract]   [Full Text] [Related]  

  • 36. Doctor-patient concordance in a placebo-controlled trial of limbitrol versus its components [proceedings].
    Jacobson AF
    Psychopharmacol Bull; 1978 Jul; 14(3):61-3. PubMed ID: 353872
    [No Abstract]   [Full Text] [Related]  

  • 37. Global ratings compared to rating scales in evaluating trifluoperazine-amobarbital in anxious psychoneurotic outpatients.
    Bercel NA
    Behav Neuropsychiatry; 1971; 2(11):15-9. PubMed ID: 4935767
    [No Abstract]   [Full Text] [Related]  

  • 38. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
    Rey A; Bovet J; Schneider PB
    Pharmatherapeutica; 1984; 4(1):13-20. PubMed ID: 6150491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial of benzoctamine versus chlordiazepoxide in anxiety neurosis.
    Lo WH; Lo T
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):48-53. PubMed ID: 4566124
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety.
    Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.